2020
Alan Parent, M.D., F.A.C.S.
Premium IOL pharmacology and determining the patient’s needs, wants, and interest for cataract surgery.
Sarah B. Muenk, M.D.
The history, causes, and different types of therapies for treating severe dry eye.
Amanda Salter, M.D.
New ophthalmic medications like, steroids, allergy, glaucoma, antivirals, ocular surface, anti-VEGF, gene therapy, and combination drops from 2017-2019.
Felise May Barte-Parent, M.D.
The background, risk factors, studies, and new changes to the treatments for glaucoma.
Nathan Cutler, M.D.
Anti-VEGF treatments, specifically new and under-development therapies.
2019
Alan Parent, M.D., F.A.C.S.
The future of cataract surgery. Where are we now and where can we go from here.
Amanda Salter, M.D.
What is dry eye syndrome and what can we do to diagnose and treat this disease.
The history, pharmacology, and products available for Botox and dermal filler.
Felise May Barte-Parent, M.D.
Disease characteristics, symptoms, and treatments for glaucomatous optic neuropathy, optic nerve pallor, optic atrophy, and visual pathway lesions.
Compare the different options for minimally-invasive glaucoma surgery (MIGS).
Susan Malinowski, M.D.
UGH Plus Syndrome, Plaquenil toxicity, melanomas, HORV, and intraocular foreign bodies are all retinal findings not to miss.
2018
Alan Parent, M.D., F.A.C.S
Genetic inheritance, expression, and therapy for ophthalmic pathologies.
Endophthalmitis signs, symptoms, treatment, and the difference between Endophthalmitis and Toxic Anterior Segment Syndrome.
Marilynn Sultana, M.D., F.A.C.S.
Emerging glaucoma therapy and how to target elevated intraocular pressures.
2017
Alan Parent, M.D., F.A.C.S
Cataract surgery and the shift to advanced technology intraocular lenses.
Marilynn Sultana, M.D., F.A.C.S.
The clinical presentations and available therapies of herpes simplex keratitis.
Felise May Barte-Parent, M.D.
Clinical Pearls for the Other Glaucomas with case study examples.
Randee M. Watson, M.D.
AREDS and AREDS2 studies and calculating risk of progression, future research, and treatment of Dry Age Related Macular Degeneration.
The overview of technology for an OCT and the indications for macular OCT, interpretations and practical examples, and the future of OCT.
2016
Adrea R. Benkoff, M.D.
The pathology, diagnosis, and management of Ectopia Lentis and its relation to Marfan’s Syndrome.
Alan Parent, M.D., F.A.C.S
Which patients are candidates for laser-assisted in situ keratomileusis (LASIK) versus advanced surface ablation (ASA).
Marilynn Sultana, M.D., F.A.C.S.
The pathophysiology, risk factors, and treatment for Primary Angle-Closure Glaucoma and Secondary Angle-Closure Glaucoma.